Huarun Pharmaceutical (300110.SZ): The application for the listing of Isoprenaline Hydrochloride chemical raw material has been approved.

Tencent Finance News reported that Huarun Pharmaceutical (300110.SZ) announced that its wholly-owned subsidiary Anhui Hengxing Pharmaceutical Co., Ltd. (referred to as "Anhui Hengxing Pharmaceutical") has received the "Approval Notice for Listing Application of Isoprenaline Hydrochloride" issued by the National Medical Products Administration.